natgillin/translations-raw huggingface dataset:
CoAprovel 150 mg/12,5 mg filmovertrukne tabletter er ferskenfarvet, bikonvekse, ovalformede med et hjerte præget på den ene side og nummeret 2875 på den anden side.
CoAprovel 150 mg/12.5 mg film-coated tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2875 engraved on the other side.
CoAprovel 150 mg/12,5 mg filmovertrukne tabletter.
CoAprovel 150 mg/12.5 mg film-coated tablets.
CoAprovel 150 mg/12,5 mg kan gives til patienter, hvis blodtryk ikke kan reguleres tilstrækkeligt med hydrochlorthiazid eller irbesartan 150 mg alene;
CoAprovel 150 mg/12.5 mg may be administered in patients whose blood pressure is not adequately controlled with hydrochlorothiazide or irbesartan 150 mg alone;
CoAprovel 150 mg/12,5 mg tabletter
CoAprovel 150 mg/12.5 mg tablets.
CoAprovel 150 mg/12,5 mg tabletter er ferskenfarvet, bikonvekse, ovalformede med et hjerte præget på den ene side og nummeret 2775 på den anden side.
CoAprovel 150 mg/12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2775 engraved on the other side.
CoAprovel 300 mg/12,5 mg filmovertrukne tabletter er ferskenfarvet, bikonvekse, ovalformede med et hjerte præget på den ene side og nummeret 2876 på den anden side.
CoAprovel 300 mg/12.5 mg film-coated tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2876 engraved on the other side.
CoAprovel 300 mg/12,5 mg filmovertrukne tabletter.
CoAprovel 300 mg/12.5 mg film-coated tablets.
CoAprovel 300 mg/12,5 mg kan gives til patienter, der er utilstrækkeligt regulerede med irbesartan 300 mg eller med CoAprovel 150 mg/12,5 mg.
CoAprovel 300 mg/12.5 mg may be administered in patients insufficiently controlled by irbesartan 300 mg or by CoAprovel 150 mg/12.5 mg.
CoAprovel 300 mg/12,5 mg tabletter
CoAprovel 300 mg/12.5 mg tablets.
CoAprovel 300 mg/12,5 mg tabletter er ferskenfarvet, bikonvekse, ovalformede med et hjerte præget på den ene side og nummeret 2776 på den anden side.
CoAprovel 300 mg/12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2776 engraved on the other side.
CoAprovel 300 mg/25 mg filmovertrukne tabletter er lyserød, bikonvekse, ovalformede med et hjerte præget på den ene side og nummeret 2788 på den anden side.
CoAprovel 300 mg/25 mg film-coated tablets are pink, biconvex, oval-shaped, with a heart debossed on one side and the number 2788 engraved on the other side.
CoAprovel 300 mg/25 mg filmovertrukne tabletter.
CoAprovel 300 mg/25 mg film-coated tablets.
CoAprovel 300 mg/25 mg kan gives til patienter, der er utilstrækkeligt regulerede med CoAprovel 300 mg /12,5 mg.
CoAprovel 300 mg/25 mg may be administered in patients insufficiently controlled by CoAprovel 300 mg/12.5 mg.
CoAprovel 300 mg/25 mg kan gives til patienter, der er utilstrækkeligt regulerede med CoAprovel 300 mg/12,5 mg.
CoAprovel 300 mg/25 mg may be administered in patients insufficiently controlled by CoAprovel 300 mg/12.5 mg.
CoAprovel 300 mg/25 mg tabletter irbesartan/hydrochlorthiazid
CoAprovel 300 mg/25 mg tablets irbesartan/hydrochlorothiazide
CoAprovel indeholder hydroclorthiazid og kan derfor ikke anbefales under graviditetens første trimester.
Since CoAprovel contains hydrochlorothiazide, it is not recommended during the first trimester of pregnancy.
CoAprovel kan tages med og uden mad.
CoAprovel can be taken with or without food.
CoAprovel må ikke gives til børn og unge (under 18 år).
CoAprovel should not be given to children and adolescents (under 18 years).
CoAprovel skal tages gennem munden.
CoAprovel is for oral use.
Coatingmiddel (blå) bestående af:Hypromellose (E464) Titandioxid (E 171)
Coating agent (blue) consisting of: Hypromellose (E464)
Coatingmiddel (hvid) bestående af: Hypromellose (E464) Lactosemonohydrat
Coating agent (white) consisting of: Hypromellose (E464)
Coatingmiddel (orange) bestående af Hypromellose (E464)
Coating agent (orange) consisting of: Hypromellose (E464)
Cobicistat (150 mg flerdosis)
Cobicistat (150 mg multiple doses)
Cobicistat (150 mg én gang dagligt)
Cobicistat (150 mg once daily)
Cobicistat behandler ikke hiv direkte, men forhøjer niveauet af atazanavir i blodet.
Cobicistat, does not directly treat your HIV, but boosts the levels of atazanavir in the blood.
Cobicistat er en hæmmer af de følgende transportere: P-glykoprotein (P-gp), brystcancer- resistensprotein (BCRP), organisk aniontransporterende polypeptid (OATP) 1B1 og OATP1B3.
Cobicistat is an inhibitor of the following transporters: P-glycoprotein (P-gp), breast cancer resistance protein (BCRP), organic anion transporting polypeptide (OATP) 1B1 and OATP1B3.
Cobicistat er en potent CYP3A-hæmmer.
Cobicistat is a potent CYP3A inhibitor.
Cobicistat er ikke blevet undersøgt hos patienter over 65 år.
Cobicistat has not been studied in patients over the age of 65.
Cobicistat er ikke indiceret til brug to gange dagligt eller til brug hos den pædiatriske population.
Cobicistat is not indicated for use in twice daily regimens or for use in the pediatric population.
Cobicistat er ikke undersøgt hos patienter med svært nedsat leverfunktion (Child-Pugh klasse C).
Cobicistat has not been studied in patients with severe hepatic impairment (Child-Pugh Class C).
Cobicistat forstærker virkningen af darunavir ved at forlænge det tidsrum, hvor det virker i kroppen.
Cobicistat acts as a ‘booster’ to enhance the effects of darunavir, by prolonging the time in which it acts in the body.
cobicistat forventes at øge
cobicistat is expected to increase
Cobicistat har til formål at øge virkningen af elvitegravir ved at forlænge det tidsrum, hvor det virker i kroppen.
Cobicistat serves to enhance the effects of elvitegravir, by prolonging the time in which it acts in the body.
Cobicistat hæmmer transportstofferne p-glycoprotein (P-gp), BCRP, MATE1, OATP1B1 og OATP1B3.
Cobicistat inhibits the transporters p-glycoprotein (P-gp), BCRP, MATE1, OATP1B1 and OATP1B3.
cobicistat må ikke anvendes i
cobicistat should not be used in
Cobicistat og præparater indeholdende cobicistat
Cobicistat and cobicistat- containing products
cobicistat reducerer kreatinin-
cobicistat lowers the creatinine
cobicistat, en booster (farmakokinetisk forstærkende stof) af elvitegravirs virkning
cobicistat, a booster (pharmacokinetic enhancer) of the effects of elvitegravir
cobicistat, må ikke anvendes i
cobicistat should not be used in
cobicistat-plasmakoncentrationen.
concentrations.
Cobicistat: AUC: ↑ 53 %
Cobicistat: AUC: ↑ 53
Cobicistat: AUC: ↓ 84 %
Cobicistat: AUC: ↓ 84
Cobicistat: AUC: ↔
AUC: ↔
cobicistats CYP2D6-hæmning.
inhibition of CYP2D6 by
cobicistats CYP3A4-hæmning.
The mechanism of interaction is CYP3A4 inhibition by cobicistat.
Cobicistats farmakokinetik er ikke blevet fuldt evalueret hos forsøgspersoner med samtidig infektion med hepatitis B- og/eller hepatitis C-virus.
Pharmacokinetics of cobicistat have not been fully evaluated in hepatitis B and/or C virus co-infected subjects.
Cobicistats hæmning af CYP3A-medieret metabolisme øger den systemiske eksponering over for CYP3A-substrater, såsom atazanavir, som har begrænset biotilgængelighed og en kort halveringstid på grund af den CYP3A-afhængige metabolisme.
Inhibition of CYP3A-mediated metabolism by cobicistat enhances the systemic exposure of CYP3A substrates, such as atazanavir, where bioavailability is limited and half-life is shortened by CYP3A- dependent metabolism.
cobicistats P-gp-hæmning.
inhibition of P-gp by cobicistat.
cobicistats potentielle hæmning
potential inhibition of the
Cobicistats sikkerhed er baseret på 144 ugers data fra et randomiseret, aktivt-kontrolleret klinisk fase 3-studie (GS-US-216-0114), i hvilket 692 behandlingsnaive patienter fik mindst én dosis cobicistat- boostet atazanavir (n = 344) eller ritonavir-boostet atazanavir (n = 348) administreret med embricitabin og tenofovirdisoproxilfumarat i fastdosis-kombination.
The safety of cobicistat is based on 144-week data from a phase 3, randomised, active-controlled clinical study (GS-US-216-0114), in which 692 treatment-naïve patients received at least one dose of cobicistat-boosted atazanavir (n = 344) or ritonavir-boosted atazanavir (n = 348) administered with emtricitabine and tenofovir disoproxil fumarate fixed-dose combination.
Cobicistats virkning på serum-kreatinin og eGFR hos patienter, som skiftede fra ritonavir til cobicistat i studie GS-US-236-0118, var konsistent med virkningen hos behandlingsnaive patienter i studie GS-US-216-0114.
The effect of cobicistat on serum creatinine and eGFR in patients switching from ritonavir to cobicistat in study GS-US-236-0118 was consistent with the effect in treatment-naïve patients in study GS-US-216-0114.
Coccidioidomykose hos patienter med sygdom, hvor behandling med amphotericin B, itraconazol eller fluconazol har været utilstrækkelig, eller hos patienter med intolerans over for disse lægemidler.
Coccidioidomycosis in patients with disease that is refractory to amphotericin B, itraconazole or fluconazole or in patients who are intolerant of these medicinal products.
Coccidioidomykose hos patienter med sygdom, hvor behandling med amphotericin B, itraconazol eller fluconazol har været utilstrækkelig, eller hos patienter med intolerans over for disse lægemidler;
Coccidioidomycosis in patients with disease that is refractory to amphotericin B, itraconazole or fluconazole or in patients who are intolerant of these medicinal products;
Coccidiose:
Coccidia:
Cochenillecarminsyre (E120) Indigocarmin (E132) Titandioxid (E171)
Cochineal carminic acid (E120) Indigo carmine (E132) Titanium dioxide (E171)
Colchicin
Alfuzosin
Colchicin
Sildenafil
colchicin (bruges til at behandle urinsyregigt), hvis du har nyre- og/eller leverproblemer. ticagrelor (bruges til at behandle blodpropper).
colchicine (used to treat gout), if you have kidney and/or liver problems ticagrelor (used to reduce the blood clots)
colchicin (medicin til behandling af urinsyregigt) – patienter med nedsat nyre- eller leverfunktion;
colchicine (anti-gout medicine) – patients with renal or hepatic impairment;
Colchicin (mod podagraanfald eller familiær middelhavsfeber)
Colchicine (for gout-flares or Mediterranean fever)
colchicin (mod uinsur gigt) nogle calciumantagonister (f.eks. verapamil, nifedipin, felodipin).
colchicine (for gout) some calcium channel blockers (e.g. verapamil, nifedipine, felodipine) (for heart disorders).
Colchicin (mod urinsyregigt), da Norvir kan øge niveauet af dette lægemiddel i blodet.
Colchicine (for gout) as Norvir may raise the blood levels of this medicine.
Colchicin (P-gp-substrat)
Colchicine (P-gp substrate)
colchicin (til behandling af urinsur gigt)
Colchicine (to treat gout)
Colchicin enkelt dosis
Colchicine single dose
colchicin er kontraindiceret til patienter
Kaletra with colchicine in patients
colchicin hos patienter med nedsat nyre- eller leverfunktion
colchicine in patients with renal or hepatic impairment
colchicin hos patienter med nedsat nyrefunktion på grund af øget risiko for svære bivirkninger.
colchicine in patients with renal impairment due to an increased risk of severe adverse reactions
colchicin hos patienter, som har alvorlige problemer med deres lever eller nyrer
colchicine in patients who have severe problems with their liver or kidneys
Colchicin Koncentrationen af colchicin forventes at stige ved indgift sammen med ritonavir.
Colchicine Concentrations of colchicine are expected to increase when coadministered with ritonavir.
Colchicin plasmakoncentrationen kan øges ved samtidig administration af EVOTAZ.
Colchicine plasma concentrations may be increased when co- administered with EVOTAZ.
colchicin til patienter med normal nyre- og lever- funktionstest
colchicine for patients whose kidney and liver function test are normal
colchicin – anvendes til behandling af urinsyregigt
colchicine – used to treat gout
colchicin – bruges til at behandle gigt
colchicine – used to treat gout
colchicin, der anvendes til behandling af podagra
colchicine: medicine to treat gout
colchicin, der bruges til behandling af urinsyregigt
colchicine, used for gout attack,
colchicin, et lægemiddel, der anvendes til at behandle podagra
colchicine, a medicine used to treat gout
colchicin, et lægemiddel, der anvendes til behandling af podagra.
colchicine, a medicine used to treat gout
Colchicin, til behandling af urinsyregigt.
Colchicine, used to treat gout.
colchicin-dosis nedsættes eller
colchicine dosage or an
colchicin-relaterede alvorlige og
colchicine-related serious and/or
colchicin.
colchicine prescribing
colchicin: et lægemiddel, der bruges til at behandle podagra-anfald
colchicine: a medicine to treat gout attacks.
Coleraine Nordirland BT51 3RP
Northern Ireland BT51 3RP
Colestilan reducerede signifikant LDL-cholesterol i serum med 17,8, 25,6, 29,4, 34,8 og 33,4 % ved
Colestilan significantly reduced serum LDL-cholesterol by 17.8, 25.6, 29.4, 34.8 and 33.4% at
colestyramin (bruges til at reducere kolesteroltallet og til at behandle kløe forbundet med gulsot) eller aktivt kul, da disse lægemidler kan nedsætte den mængde Repso, der optages i kroppen.
Colestyramine (used to lower cholesterol levels and treat itching associated with jaundice) or activated charcoal as these medicines can reduce the amount of Repso absorbed by your body.
colestyramin - bruges til behandling af forhøjet kolesterol rifampicin – et antibiotikum, som bruges til forebyggelse og behandling af infektioner såsom tuberkulose (TB)
cholestyramine - used to treat high cholesterol rifampicin - an antibiotic used to prevent and treat infections such as tuberculosis (TB)
colestyramin - bruges til behandling af forhøjet kolesterol rifampicin – et antibiotikum, som bruges til forebyggelse og behandling af infektioner såsom tuberkulose (TB)
cholestyramine – used to treat high cholesterol rifampicin – an antibiotic used to prevent and treat infections such as tuberculosis (TB)
colestyramin - bruges til behandling af forhøjet kolesterol rifampicin – et antibiotikum, som bruges til forebyggelse og behandling af infektioner såsom tuberkulose (TB) fosfatbindere - bruges til mennesker med kronisk nyresvigt for at reducere absorptionen af fosfat til blodet.
cholestyramine – used to treat high cholesterol rifampicin – an antibiotic used to prevent and treat infections such as tuberculosis (TB) phosphate binders – used by people with chronic kidney failure to reduce how much phosphate gets absorbed into their blood.
colestyramin 8 g 3 gange dagligt i 11 dage,
colestyramine 8 g is administered 3 times daily for a period of 11 days,
colestyramin 8 g 3 gange dagligt i 11 dage, eller 50 g aktivt kul 4 gange dagligt i 11 dage.
colestyramine 8 g is administered 3 times daily for a period of 11 days, alternatively, 50 g of activated powdered charcoal is administered 4 times daily for a period of 11 days.
Colestyramin 8 g 3 gange dagligt i 11 dage.
Colestyramine 8 g is administered 3 times daily for a period of 11 days.
colestyramin mod forhøjet kolesterol eller mod kløe ved leversygdom aktivt kul for at reducere optagelsen af medicin eller andre stoffer
cholestyramine for high cholesterol or relief from itching in liver disease activated charcoal to reduce absorption of medicines or other substances
colestyramin og colestipol eller andre ionbytterresiner (medicin, der primært bruges til behandling af forhøjet fedtniveau i blodet).
cholestyramine, colestipol or other resins (substances used mainly to treat high levels of lipids in the blood).
colestyramin og colestipol eller andre ionbytterresiner (medicin, der primært bruges til behandling af forhøjet fedtniveau i blodet);
cholestyramine, colestipol or other resins (substances used mainly to treat high levels of lipids in the blood).
colestyramin og colestipol eller andre ionbytterresiner (medicin, der primært bruges til behandling af forhøjet fedtniveau i blodet);
cholestyramine, colestipol or other resins (substances used mainly to treat high levels of lipids in the blood);
Colestyramin og colestipol, medicin til at sænke blodets fedtindhold.
Cholestyramine and colestipol, medicines for lowering blood fat levels.
Colibacillose kan forårsage skader på hjertesækken (perikarditis), på vævet omkring leveren (perihepatitis) og på luftsækkene, de særlige hulrum i fuglens krop, hvor der opbevares luft under vejrtrækningen (airsacculitis), og bevirke, at fuglen dør.
Colibacillosis can cause injuries to the sac that surrounds the heart (pericarditis), the sac surrounding the liver (perihepatitis) and the ‘air sacs’, the specialised bags within the bird’s body where air is stored during breathing (airsacculitis), and can lead to death of the bird.
Coliprotec F4, lyofilisat til oral suspension, til svin
Coliprotec F4 lyophilisate for oral suspension for pigs
Coliprotec F4, lyofilisat til oral suspension, til svin.
Coliprotec F4 lyophilisate for oral suspension for pigs.
Colitis
Colit is
colitis
colitis,
colitis
Colitis.
Colitis (betændelse i tyktarmen, som kan ledsages af blødning fra tarm eller endetarm)
colitis (inflammation of the lining of the large bowel, which may be accompanied by intestinal or rectal bleeding)
Colitis (inkl. clostridium difficile)*
Colitis (inc clostridium difficile)
Colitis (inklusive colitis
Colitis (including
colitis (mikroskopisk colitis og enterocolitis)
colitis (colitis microscopic and enterocolitis)
Colitis forekom hos 48 (1,7%) patienter, som fik pembrolizumab, inklusive tilfælde af grad 2, 3 eller 4 hos henholdsvis 10 (0,4%), 31 (1,1%) og 2 (< 0,1%) patienter.
Colitis occurred in 48 (1.7%) patients, including Grade 2, 3 or 4 cases in 10 (0.4%), 31 (1.1%) and 2 (<0.1%) patients, respectively, receiving pembrolizumab.
Colitis forårsaget af antibakterielle lægemidler, inkl. pseudomembranøs colitis (svær eller vedvarende diarré indeholdende blod og/eller slim og forbundet med mavesmerte eller feber).
Antibacterial-associated colitis, including pseudomembranous colitis (severe or persistent diarrhoea containing blood and/or mucus, associated with abdominal pain or fever).
Colitis Gastritis Gingival- blødning
Colitis Gastritis Gingival bleeding
Colitis gik over hos 41 patienter.
Colitis resolved in 41 patients.
Colitis medførte seponering af pembrolizumab hos 15 (0,5%) patienter.
Colitis led to discontinuation of pembrolizumab in 15 (0.5%) patients.
Colitis ulcerosa (børn)
Paediatric Ulcerative colitis
colitis ulcerosa (en sygdom, som giver betændelse og sår i tarmvæggen),
ulcerative colitis (a disease causing inflammation and ulcers in the lining of the gut);
Colitis ulcerosa er en betæ ndelsessygdom i tarmen.
Ulcerative colitis is an inflammatory disease of the bowel.
Colitis ulcerosa er en inflammatorisk sygdom i tyktarmen.
Ulcerative colitis is an inflammatory disease of the large intestine.
Colitis ulcerosa hos børn (6 til 17 år)
Paediatric ulcerative colitis (6 to 17 years)
Colitis ulcerosa hos voksne
Adult psoriatic arthritis
Colitis ulcerosa, børn
Paediatric ulcerative colitis
Colitis ulcerosa, børn
Paediatric ulcerative colitis patients
Colitis ulcerosa.
Ulcerative colitis.
Colitis ulcerosa٭
Ulcerative colitis
colitis,
colit is,
Colitis,
Jaundice
Colitis,
reflux disease, Colitis,
colitis, diarre, opkastning, kvalme, abdominalsmerter
colitis, diarrhoea, vomiting, nausea, abdominal pain
colitis, myko-
Mycobacterial
colitis, stomatitis, opkastning, abdominalsmerter, obstipation, mundtørhed
colitis, stomatitis, vomiting, abdominal pain, constipation, dry mouth
colitis, ulcus duodeni
colitis, duodenal ulcer
colitisg, opkastning, abdominalsmerterh, obstipation, mundtørhed
colitisg, vomiting, abdominal painh, constipation, dry mouth
Collier med deficient multidrug-resistance-protein 1 (MDR1 -/-) kan godt tåle en enkelt dosis oralt, når de får 5 gange den anbefalede dosis.
Sarolaner is well tolerated in Collies with a deficient multidrug-resistance-protein 1 (MDR1 -/-) following single oral administration at 5 times the recommended dose.
Colobreathe (Middelværdi)
Colobreathe ( Mean)
Colobreathe 1.662.500 IE inhalationspulver i kapsler
Colobreathe 1,662,500 IU inhalation powder, hard capsules
Colobreathe 1.662.500 IU inhalationspulver i kapsler.
Colobreathe 1,662,500 IU inhalation powder, hard capsules
Colobreathe anvendes til behandling af langvarig lungebetændelse forårsaget af bakterien Pseudomo- nas aeruginosa hos patienter over 60 år med cystisk fibrose.
Colobreathe is used to manage long-term lung infection caused by the bacteria Pseudomonas aeruginosa in patients aged six years and over who have cystic fibrosis.
Colobreathe bør ikke anvendes hos patienter, der er overfølsomme (allergiske) over for colistimethat- natrium, colistinsulfat eller polymyxin B.
Colobreathe must not be used in people who are hypersensitive (allergic) to colistimethate sodium or to colistin sulphate or polymyxin B.
Colobreathe fås i forpakninger, der indeholder enten 8 eller 56 hårde kapsler.
Colobreathe is available in packs containing either 8 or 56 hard capsules.
Colobreathe medførte ikke alvorligere bivirk- ninger end tobramycin.
No more serious side effects were seen with Colobreathe than with tobramycin.
Colobreathe virker ved at ødelægge bakteriernes cellemembran, hvorved cellerne dør.
Colobreathe works by destroying the bacterial cell membrane, having a lethal effect on them.
Colobreathe-kapsler bør udelukkende administreres ved anvendelse af Turbospin-inhalatorenhed.
Colobreathe capsules should only be administered using the Turbospin inhaler device.
Coloque en una cucharilla la dosis indicada (preferiblemente ya en pedazos si toma Siklos 1000 mg) y añada agua.
Place the required dose (preferably broken if Siklos 1000 mg tablet is used) in a teaspoon and add some water.
Color mixture blue (polydextose, hypromellose, glyceroltriacetat, macrogol 8000, titandioxid E171, indigocarmin E132)
Colour mixture blue (polydextrose, hypromellose, glycerol triacetate, macrogol 8000, titanium dioxide E171,indigo carmine E132)
Color mixture pink (polydextose, hypromellose, glyceroltriacetat, macrogol 8000, titandioxid E171, rød jernoxid E172).
Colour mixture pink (polydextrose, hypromellose, glycerol triacetate, macrogol 8000, titanium dioxide E171, iron oxide red E172)
Color mixture white (polydextose, hypromellose, glyceroltriacetat, macrogol 8000, titandioxid E171)
Colour mixture white (polydextrose, hypromellose, glycerol triacetate, macrogol 8000, titanium dioxide E171)
Colour mixture white (hypromellose, titandioxid E171, macrogol, polysorbat 80) Carnaubavoks
Colour mixture white (hypromellose, titanium dioxide E171, macrogol, polysorbate 80)
coma, heriblandt
coma, including
coma, heriblandt
Glucosuria
Combivir 150 mg/300 mg filmovertrukne tabletter
Combivir 150 mg/300 mg film-coated tablets
Combivir 150 mg/300 mg filmovertrukne tabletter lamivudin/zidovudin
Combivir 150 mg/300 mg film-coated tablets Lamivudine/zidovudine
Combivir 150 mg/300 mg tabletter lamivudin/zidovudin
Combivir 150 mg/300 mg tablets Lamivudine/zidovudine
Combivir bør ikke anvendes til patienter, som kan være overfølsomme (allergiske) over for lamivudin, zidovudin eller andre af indholdsstofferne.
Combivir should not be used by people who may be hypersensitive (allergic) to lamivudine, zidovudine or any of the other ingredients.
Combivir er en fastdosiskombination af lamivudin og zidovudin
Combivir is a fixed dose combination of lamivudine and zidovudine
Combivir er et lægemiddel, der indeholder de to aktive stoffer lamivudin (150 mg) og zidovudin (300 mg).
Combivir is a medicine that contains two active substances, lamivudine (150 mg) and zidovudine (300 mg).
Combivir helbreder ikke hiv-infektion eller aids, men kan sinke den skade på immunsystemet og de infektioner og sygdomme, der er forbundet med aids.
Combivir does not cure HIV infection or AIDS, but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS.
Combivir i kombination med mindst ét andet antiviralt lægemiddel nedsætter hiv-mængden i blodet og holder den nede.
Combivir, taken in combination with at least one other antiviral medicine, reduces the amount of HIV in the blood and keeps it at a low level.
Combivir kan tages med eller uden mad.
Combivir may be administered with or without food.
Combivir lamivudin og zidovudin
Combivir lamivudine and zidovudine